Improvement in 3 noninvasive tests through 144 weeks of bulevirtide monotherapy in patients with chronic hepatitis Delta with and without virologic response - Brunetto, M; Aleman, S; Andreone, P; Bogomolov, P; Chulanov, V; Geyvandova, N; Morozov, V; Sagalova, O; Stepanova, T; Deterding, K; Lichtman, A; Mercier, R-C; Manuilov, D; Li, M; Schulze zur Wiesch, J; Zeuzem, S; Wedemeyer, H; Lampertico, P (Zeitschrift für Gastroenterologie, 2025)